Akash Virupakshaiah

23PUBLICATIONS
90CO-AUTHORS
Medical infection agents (incl. prions)AllergyInfant and child healthPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 21, 2026
Reduced Paramagnetic Rim Visibility Signals Lesion Aging and Tissue Degeneration in Progressive Multiple Sclerosis: Impact on Clinical Trials.

|Aug 07, 2026
Acute Attack Treatment Escalation and Subsequent Relapse Risk in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

|Jun 24, 2026
Adaptation of the Transition Readiness Assessment Questionnaire for Pediatric-Onset Multiple Sclerosis: Protocol for a User-Centered Design Approach.

|Jun 11, 2026
High-dose N-acetyl cysteine reduces GFAP levels: Exploratory results from a pilot double-blind, placebo-controlled randomized trial.

|May 29, 2026
Adenotonsillectomy is associated with increased risk and disease activity in pediatric-onset multiple sclerosis.

|May 14, 2026
The Effect of Ocrelizumab on Anti-JC Virus Antibody Index.

Pageof 4

Frequent Collaborators

11 joint publications

Vinicius Schoeps

10 joint publications

Emmanuelle Waubant

8 joint publications

Aaron W Abrams

8 joint publications

Tanuja Chitnis